Metabolic studies in carcinoid syndrome: observations on use of alpha-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency.
作者信息
DAVIS R B, ALEXANDER C S, ADICOFF A
出版信息
Metabolism. 1961 Dec;10:1035-44.
PMID:13883956
Abstract
摘要
相似文献
1
2
Serotonin synthesis in carcinoid patients. Its inhibition by alpha-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan.
N Engl J Med. 1960 Sep 22;263:585-8. doi: 10.1056/NEJM196009222631204.
3
[Trial of alpha-methyl-dopa in a case of carcinoidosis].
Pathol Biol. 1962 Jan;10:75-7.
4
[Carcinoid syndrome (apropos of 1 case). II. Biologic study and therapeutic note].
Bull Mem Soc Med Hop Paris. 1967 Feb 23;119(4):403-12.
5
Effect of methyldopa in carcinoid disease.
Br Med J. 1962 Oct 13;2(5310):961-3. doi: 10.1136/bmj.2.5310.961.
6
[On the therapeutic use of alpha-methyl-DOPA in the carcinoid syndrome].
Klin Wochenschr. 1961 Sep 15;39:973. doi: 10.1007/BF01482661.
7
A case of carcinoid syndrome, with an account of the use of alpha-methyl-dopa.
Med J Aust. 1961 Oct 7;48(2):589-92. doi: 10.5694/j.1326-5377.1961.tb69829.x.
8
[Biological study of a case of carcinoidosis; therapeutic perspectives].
Lyon Med. 1962 Feb 11;94:289-99.
9
The effects of alpha-methyl-DOPA and alpha-methyl-metatyrosine on the metabolism of norepinephrine and serotonin in vivo.
J Pharmacol Exp Ther. 1961 Nov;134:129-38.
10
Use of alpha-methyl-dopa (alpha-methyl-3,4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome.
N Engl J Med. 1961 May 11;264:986-7. doi: 10.1056/NEJM196105112641907.
引用本文的文献
1
Effect of methyldopa in carcinoid disease.
Br Med J. 1962 Oct 13;2(5310):961-3. doi: 10.1136/bmj.2.5310.961.
2
Tryptophan in the treatment of carcinoid crisis.
Cancer Chemother Pharmacol. 1983;10(2):137-9. doi: 10.1007/BF00446228.
Zotero 插件